https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-27 / Trials 2019 Apr;20(1):242
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-27 / Trials 2019 Apr;20(1):2422019-04-27 00:00:002021-05-19 15:22:19A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-24 / Front Immunol 2019;10:874
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-24 / Front Immunol 2019;10:8742019-04-24 00:00:002019-04-24 00:00:00Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-23 / Saudi J Biol Sci 2020 Jan;27(1):47-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-23 / Saudi J Biol Sci 2020 Jan;27(1):47-522019-04-23 00:00:002020-08-26 14:21:10Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-20 / Chin. Med. J. 2019 Apr;132(8):922-927
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-20 / Chin. Med. J. 2019 Apr;132(8):922-9272019-04-20 00:00:002019-04-20 00:00:00Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-15 / Cancers (Basel) 2019 Apr;11(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-15 / Cancers (Basel) 2019 Apr;11(4)2019-04-15 00:00:002019-04-15 00:00:00A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-12 / Int J Mol Sci 2019 Apr;20(8)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-12 / Int J Mol Sci 2019 Apr;20(8)2019-04-12 00:00:002019-04-12 00:00:00Curcumin: New Insights into an Ancient Ingredient against Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-11 / Front Immunol 2019;10:766
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-11 / Front Immunol 2019;10:7662019-04-11 00:00:002019-07-01 08:10:01Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-08 / EBioMedicine 2019 May;43:201-210
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-08 / EBioMedicine 2019 May;43:201-2102019-04-08 00:00:002019-04-08 00:00:00Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-464
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-05 / Surg. Oncol. Clin. N. Am. 2019 Jul;28(3):447-4642019-04-05 00:00:002019-04-05 00:00:00Immunotherapy in Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-04 / BMC Cancer 2019 Apr;19(1):315
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-04 / BMC Cancer 2019 Apr;19(1):3152019-04-04 00:00:002020-12-14 17:17:19Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
